255 related articles for article (PubMed ID: 26261522)
1. Association of ultrasonographic features with NGX6 expression and prognosis in invasive ductal breast carcinoma.
Xiao J; Zhou Y; Zhu W
Int J Clin Exp Pathol; 2015; 8(6):6458-65. PubMed ID: 26261522
[TBL] [Abstract][Full Text] [Related]
2. High expression of heat shock protein 10 correlates negatively with estrogen/progesterone receptor status and predicts poor prognosis in invasive ductal breast carcinoma.
Chu S; Wen Q; Qing Z; Luo J; Wang W; Chen L; Feng J; Xu L; Zang H; Fan S
Hum Pathol; 2017 Mar; 61():173-180. PubMed ID: 27993580
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
Chen Y; Song J; Jiang Y; Yu C; Ma Z
Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
[TBL] [Abstract][Full Text] [Related]
4. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
[TBL] [Abstract][Full Text] [Related]
5. Prognostic importance of ultrasound BI-RADS classification in breast cancer patients.
Kim JY; Jung EJ; Park T; Jeong SH; Jeong CY; Ju YT; Lee YJ; Hong SC; Ha WS; Choi SK
Jpn J Clin Oncol; 2015 May; 45(5):411-5. PubMed ID: 25670765
[TBL] [Abstract][Full Text] [Related]
6. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.
Cao YW; Li WQ; Wan GX; Li YX; Du XM; Li YC; Li F
J Exp Clin Cancer Res; 2014 Nov; 33(1):97. PubMed ID: 25420528
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract][Full Text] [Related]
9. The Relation of Parafibromin Expression with Clinicopathological Factors in Invasive Breast Carcinomas.
Karaarslan S; Genç B; Nart A; Börekçi İ; Buğdayci MH
Turk Patoloji Derg; 2016; 32(1):8-14. PubMed ID: 26832176
[TBL] [Abstract][Full Text] [Related]
10. Negative/low HER2 expression alone or combined with E-cadherin positivity is predictive of better prognosis in patients with breast carcinoma.
Karray-Chouayekh S; Trifa F; Khabir A; Sellami-Boudawara T; Frikha M; Gargouri A; Mokdad-Gargouri R
Histol Histopathol; 2012 Mar; 27(3):377-85. PubMed ID: 22237715
[TBL] [Abstract][Full Text] [Related]
11. Lymphovascular infiltration in the tumor bed is a useful marker of biological behavior in breast cancer.
Panagiotopoulos N; Lagoudianakis E; Pappas A; Filis K; Salemis N; Manouras A; Kontzoglou K; Zografos G
J BUON; 2016; 21(5):1082-1089. PubMed ID: 27837608
[TBL] [Abstract][Full Text] [Related]
12. Gli1 is a potential cancer stem cell marker and predicts poor prognosis in ductal breast carcinoma.
Ni W; Yang Z; Qi W; Cui C; Cui Y; Xuan Y
Hum Pathol; 2017 Nov; 69():38-45. PubMed ID: 28965964
[TBL] [Abstract][Full Text] [Related]
13. LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.
Li N; Zheng Y; Xuan C; Lin Z; Piao L; Liu S
Int J Clin Exp Pathol; 2015; 8(10):12893-900. PubMed ID: 26722481
[TBL] [Abstract][Full Text] [Related]
14. BAG-1/SODD, HSP70, and HSP90 are potential prognostic markers of poor survival in node-negative breast carcinoma.
Davidson B; Valborg Reinertsen K; Trinh D; Reed W; Bøhler PJ
Hum Pathol; 2016 Aug; 54():64-73. PubMed ID: 27038683
[TBL] [Abstract][Full Text] [Related]
15. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
16. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma.
Zhao P; Lu Y; Jiang X; Li X
Cancer Sci; 2011 May; 102(5):1107-11. PubMed ID: 21276138
[TBL] [Abstract][Full Text] [Related]
18. Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues.
Cao L; Sun PL; Yao M; Jia M; Gao H
Hum Pathol; 2017 Oct; 68():166-174. PubMed ID: 28899737
[TBL] [Abstract][Full Text] [Related]
19. Expression of the cell cycle regulatory proteins p34cdc2, p21waf1, and p53 in node negative invasive ductal breast carcinoma.
Kourea HP; Koutras AK; Scopa CD; Marangos MN; Tzoracoeleftherakis E; Koukouras D; Kalofonos HP
Mol Pathol; 2003 Dec; 56(6):328-35. PubMed ID: 14645695
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic significance of ECT2 in invasive breast cancer.
Wang HK; Liang JF; Zheng HX; Xiao H
J Clin Pathol; 2018 May; 71(5):442-445. PubMed ID: 29051317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]